Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8744948 | Clinical Microbiology and Infection | 2018 | 28 Pages |
Abstract
This ESGICH consensus document constitutes not only a comprehensive overview of the molecular rationale and clinical experience on the risk of infection associated with approved targeted therapies but also an attempt to propose a series of recommendations with the purpose of guiding physicians from different disciplines into this emerging framework.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
M. Fernández-Ruiz, Y. Meije, O. Manuel, H. Akan, J. Carratalà , J.M. Aguado, J. Delaloye,